Cyclosporine A inhibits the secretion of certain anterior pituitary hormones in patients with nephrotic syndrome

Endocrinol Jpn. 1992 Feb;39(1):129-32. doi: 10.1507/endocrj1954.39.129.

Abstract

To clarify the effects of cyclosporine A (CsA) on the secretion of serum thyrotropin (TSH), prolactin (PRL), luteinizing hormone (LH) and follicular stimulating hormone (FSH), we performed TRH and LH-RH testing in 4 patients with the nephrotic syndrome before and after the administration of CsA, 6 mg/kg/day for 4 to 12 weeks. Prior to CsA all patients responded normally to TRH with respect to TSH and PRL secretion. Two patients showed normal response of LH and FSH to LH-RH stimulation while the response in 2 other patients, who were both menopausal, was exaggerated. By the third or fourth week of CsA administration the basal and peak TSH and PRL values declined significantly in all patients in response to TRH stimulation while those of LH and FSH showed only a modest decrease in response to LH-RH stimulation. Two to 4 weeks after the cessation of CsA the response of TSH, PRL and FSH returned to the pretreatment level. These observations suggest that: 1) CsA exerts an inhibitory effect on the secretion of at least TSH and PRL in humans, and 2) the effect of CsA on the pituitary may be partially reversible after the cessation of the therapy.

MeSH terms

  • Adult
  • Cyclosporine / pharmacology*
  • Female
  • Follicle Stimulating Hormone / metabolism
  • Humans
  • Luteinizing Hormone / metabolism
  • Male
  • Middle Aged
  • Nephrotic Syndrome / physiopathology*
  • Pituitary Hormones, Anterior / metabolism*
  • Prolactin / metabolism
  • Retrospective Studies
  • Thyrotropin / metabolism

Substances

  • Pituitary Hormones, Anterior
  • Cyclosporine
  • Prolactin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Thyrotropin